Income Statement (TTM)
Valerio Therapeutics Société anonyme Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3 | 2 | 2 | 1 | 3 | 4 | 4 | 3 | 2 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
| Change (%) | -34.75 | -13.88 | -16.12 | 108.30 | 51.99 | -7.25 | -7.82 | -29.23 | -41.29 | 0.00 | 0.00 | 12.37 | 11.01 | 2.47 | 2.41 | -2.54 | -2.61 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 1 |
| Change (%) | -5.71 | 0.86 | 0.86 | 2.12 | 2.08 | 6.52 | 6.12 | 11.78 | 10.54 | -2.24 | -2.29 | 4.28 | 4.10 | -5.25 | -5.54 | 3.77 | 3.64 | |
| % of Revenue | 13.52 | 19.54 | 22.88 | 27.51 | 13.49 | 9.06 | 10.40 | 11.98 | 18.92 | 35.62 | 34.82 | 34.03 | 31.58 | 29.61 | 27.38 | 25.25 | 26.89 | 28.61 |
| Gross Operating Profit | 2 | 1 | 1 | 1 | 2 | 4 | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Change (%) | -39.29 | -17.46 | -21.15 | 148.60 | 59.78 | -8.62 | -9.44 | -34.81 | -53.39 | 1.24 | 1.22 | 16.54 | 14.20 | 5.72 | 5.41 | -4.67 | -4.90 | |
| % of Revenue | 86.48 | 80.46 | 77.12 | 72.49 | 86.51 | 90.94 | 89.60 | 88.02 | 81.08 | 64.38 | 65.18 | 65.97 | 68.42 | 70.39 | 72.62 | 74.75 | 73.11 | 71.39 |
| SG&A | 8 | 8 | 8 | 8 | 8 | 8 | 10 | 13 | 15 | 18 | 19 | 20 | 20 | 20 | 18 | 17 | 16 | 14 |
| Change (%) | -2.34 | 1.06 | 1.04 | -1.23 | -1.24 | 27.63 | 21.65 | 21.50 | 17.69 | 6.19 | 5.83 | -1.67 | -1.70 | -5.54 | -5.86 | -9.92 | -11.01 | |
| % of Revenue | 306.47 | 458.73 | 538.28 | 648.40 | 307.46 | 199.78 | 274.90 | 362.77 | 622.76 | 1,248.51 | 1,325.74 | 1,402.98 | 1,227.66 | 1,087.11 | 1,002.14 | 921.18 | 851.44 | 777.97 |
| R&D | ||||||||||||||||||
| Change (%) | ||||||||||||||||||
| % of Revenue | ||||||||||||||||||
| OpEx | 10 | 10 | 10 | 10 | 10 | 10 | 12 | 13 | 16 | 19 | 20 | 22 | 21 | 21 | 20 | 20 | 19 | 18 |
| Change (%) | -4.42 | 0.54 | 0.54 | -0.26 | -0.26 | 19.85 | 16.56 | 18.87 | 15.87 | 8.22 | 7.59 | -1.74 | -1.77 | -2.40 | -2.45 | -3.96 | -4.12 | |
| % of Revenue | 368.61 | 539.98 | 630.40 | 755.57 | 361.80 | 237.42 | 306.78 | 387.91 | 651.51 | 1,285.93 | 1,391.58 | 1,497.23 | 1,309.22 | 1,158.50 | 1,103.47 | 1,051.03 | 1,035.77 | 1,019.69 |
| Operating Income | -7 | -8 | -8 | -8 | -7 | -6 | -8 | -10 | -14 | -17 | -19 | -20 | -20 | -19 | -19 | -18 | -17 | -16 |
| Change (%) | 6.87 | 3.82 | 3.68 | -16.82 | -20.22 | 39.56 | 28.35 | 35.57 | 26.24 | 8.91 | 8.18 | -2.75 | -2.83 | -2.86 | -2.94 | -4.11 | -4.28 | |
| % of Revenue | -268.61 | -439.98 | -530.40 | -655.57 | -261.80 | -137.42 | -206.78 | -287.91 | -551.51 | -1,185.93 | -1,291.58 | -1,397.23 | -1,209.22 | -1,058.50 | -1,003.47 | -951.03 | -935.77 | -919.69 |
| Interest Expense | -1 | -1 | -1 | -1 | -1 | -1 | -2 | -3 | -3 | -3 | -1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Change (%) | -2.69 | -6.83 | -7.33 | 1.21 | 1.19 | 104.54 | 51.11 | 1.30 | 1.28 | -57.92 | -93.46 | 91.89 | 47.89 | -44.29 | -17.95 | 150.52 | 30.15 | |
| % of Revenue | -36.20 | -54.00 | -58.42 | -64.54 | -31.36 | -20.88 | -46.04 | -75.47 | -108.01 | -186.35 | -78.41 | -5.13 | -8.76 | -11.67 | -6.34 | -5.08 | -13.06 | -17.46 |
| Net Income | -10 | 1 | -4 | -9 | -7 | -6 | -9 | -13 | -16 | -20 | -20 | -20 | -20 | -20 | -20 | -20 | -22 | -24 |
| Change (%) | -111.41 | -450.51 | 128.53 | -15.97 | -19.00 | 56.43 | 36.08 | 27.39 | 21.50 | 0.44 | 0.44 | 1.54 | 1.52 | -1.69 | -1.71 | 10.87 | 9.80 | |
| % of Revenue | -350.61 | 61.32 | -249.56 | -679.89 | -274.28 | -146.16 | -246.52 | -363.89 | -655.00 | -1,355.65 | -1,361.64 | -1,367.64 | -1,235.86 | -1,130.22 | -1,084.36 | -1,040.66 | -1,183.84 | -1,334.69 |
Source: Capital IQ
